These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 39326334)

  • 1. The transplantation effect of pegylated granulocyte colony-stimulating factor mobilized hematopoietic stem cells may be superior to that of G-CSF mobilized hematopoietic stem cells in haploidentical allogeneic hematopoietic cell transplantation.
    Cao J; Zhuang X; Pei R; Lu Y; Ye P; Chen D; Du X; Li S; Liu X
    Curr Res Transl Med; 2024 Dec; 72(4):103473. PubMed ID: 39326334
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Uniform Graft-versus-Host Disease Prophylaxis using Post-Transplantation Cyclophosphamide, Methotrexate, and Cyclosporine following Peripheral Blood Hematopoietic Stem Cell Transplantation from Matched and Haploidentical Donors for Transfusion-Dependent Thalassemia: A Retrospective Report from the Bone Marrow Failure Working Group of Hunan Province, China.
    Gong S; Tian X; Yang R; Yang L; Wang Z; Yang K; Chen K; He X; Deng W; Yang X; Lei M; Fu B
    Transplant Cell Ther; 2024 Dec; 30(12):1213.e1-1213.e12. PubMed ID: 39236789
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biologically Randomized Comparison of Haploidentical Versus Human Leukocyte Antigen-Matched Related Donor Reduced-Intensity Conditioning Hematopoietic Cell Transplantation.
    Grunwald MR; Sha W; He J; Sanikommu S; Gerber JM; Ai J; Knight TG; Fasan O; Boseman V; Kaizen W; Chojecki A; Ragon BK; Symanowski J; Avalos B; Copelan E; Ghosh N
    Transplant Cell Ther; 2024 Dec; 30(12):1211.e1-1211.e11. PubMed ID: 39332808
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bone marrow versus peripheral blood allogeneic haematopoietic stem cell transplantation for haematological malignancies in adults.
    Kiene S; Albrecht M; Theurich S; Scheid C; Skoetz N; Holtick U
    Cochrane Database Syst Rev; 2024 Nov; 11(11):CD010189. PubMed ID: 39508306
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Healthcare Resource Utilization and Associated Costs in Patients With Chronic Graft-Versus-Host Disease Post-Allogeneic Hematopoietic Stem Cell Transplantation in England.
    Avenoso D; Davidson JA; Larvin H; Brewer HR; Rice CT; Ecsy K; Sil A; Skinner L; Hudson RDA
    Transplant Cell Ther; 2024 Dec; 30(12):1207.e1-1207.e11. PubMed ID: 39389467
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcomes of haploidentical transplants with PT-CY vs 10/10 MUD transplants with ATG in Germany.
    Arslan A; Labuhn S; Sala E; Ringhoffer M; Schetelig J; Schröder T; Bug G; Franke GN; Stelljes M; Dreger P; Zeiser R; Teschner D; Bethge W; Eder M; Edinger M; Amann EM; Neuchel C; Schmid-Möglich A; Schmeller S; Beyersmann J; Schrezenmeier H; Mytilineos J; Kröger N; Fürst D
    Blood Adv; 2024 Dec; 8(23):6104-6113. PubMed ID: 39368803
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Retrospective clinical study on cryopreservation-free integrated autologous hematopoietic stem cell transplantation model for newly diagnosed multiple myeloma].
    Yang X; Li CL; Chen J; Che FF; Xiao R; Li H; Huang J; Jiang T; Yang HQ; Wang H; Kuang XC; Huang XB
    Zhonghua Xue Ye Xue Za Zhi; 2024 May; 45(5):488-494. PubMed ID: 38964924
    [No Abstract]   [Full Text] [Related]  

  • 8. Epidemiology of Diffuse Alveolar Hemorrhage in Pediatric Allogeneic Hematopoietic Cell Transplantation Recipients.
    Cheng G; Smith MA; Phelan R; Brazauskas R; Strom J; Ahn KW; Hamilton B; Peterson A; Savani B; Schoemans H; Schoettler M; Sorror M; Higham C; Kharbanda S; Dvorak CC; Zinter MS
    Transplant Cell Ther; 2024 Oct; 30(10):1017.e1-1017.e12. PubMed ID: 39089527
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibiotic Prophylaxis During Allogeneic Stem Cell transplantation-A Comprehensive Single Center Retrospective Analysis.
    Neuerburg CKF; Schmitz F; Schmitz MT; Rehnelt S; Schumacher M; Parčina M; Schmid M; Wolf D; Brossart P; Holderried TAW
    Transplant Cell Ther; 2024 Dec; 30(12):1195.e1-1195.e13. PubMed ID: 39299503
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Analysis of the efficacy and prognostic factors of allogeneic hematopoietic stem cell transplantation in patients with myelodysplastic syndrome with blastomycosis and survival comparison of different subtypes after the WHO 2022 reclassification].
    Wang H; Ma RZ; Pang AM; Yang DL; Chen X; Zhang RL; Wei JL; Ma QL; Zhai WH; He Y; Jiang EL; Han MZ; Feng SZ
    Zhonghua Xue Ye Xue Za Zhi; 2024 May; 45(5):445-452. PubMed ID: 38964918
    [No Abstract]   [Full Text] [Related]  

  • 11. Falls prevention interventions for community-dwelling older adults: systematic review and meta-analysis of benefits, harms, and patient values and preferences.
    Pillay J; Gaudet LA; Saba S; Vandermeer B; Ashiq AR; Wingert A; Hartling L
    Syst Rev; 2024 Nov; 13(1):289. PubMed ID: 39593159
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lamotrigine versus levetiracetam or zonisamide for focal epilepsy and valproate versus levetiracetam for generalised and unclassified epilepsy: two SANAD II non-inferiority RCTs.
    Marson AG; Burnside G; Appleton R; Smith D; Leach JP; Sills G; Tudur-Smith C; Plumpton CO; Hughes DA; Williamson PR; Baker G; Balabanova S; Taylor C; Brown R; Hindley D; Howell S; Maguire M; Mohanraj R; Smith PE
    Health Technol Assess; 2021 Dec; 25(75):1-134. PubMed ID: 34931602
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of a Modified Post-Transplant Cyclophosphamide Regimen for Unrelated Donor Hematopoietic Stem Cell Transplantation in Patients with Severe Aplastic Anemia: A Prospective Study.
    Chen X; Chen C; Zhou M; Zhang Y; Wang C; Li Y; Zhou R; Xu S; Zhou W; Deng T; Pan S; Wu L; Zhang Y; Mo W; Wang S
    Transplant Cell Ther; 2024 Nov; 30(11):1099.e1-1099.e10. PubMed ID: 39187160
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early Mixed Donor Chimerism is a Strong Negative Prognostic Indicator in Allogeneic Stem Cell Transplant for AML and MDS.
    Radford M; Garcia-Horton A; Badami R; Jin E; Usmani N; Grafodatskaya D; McCready E; Khalaf D; Walker I; Leber B; Lepic K; Pond G; Berg T
    Transplant Cell Ther; 2024 Nov; ():. PubMed ID: 39547311
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Haploidentical donor peripheral blood stem cell transplantation using third-party cord blood compared with matched unrelated donor transplantation for patients with hematologic malignancies].
    Ma X; Chen Y; Liu Y; Cheng TT; Chen X; Zeng C; Hua J; Wang SY; Xu YJ
    Zhonghua Xue Ye Xue Za Zhi; 2024 Feb; 45(2):141-147. PubMed ID: 38604790
    [No Abstract]   [Full Text] [Related]  

  • 16. Salvage hematopoietic stem cell transplantation for patients with higher leukemia burden in relapsed or refractory acute myeloid leukemia: a ten-year study.
    Jiang S; Lu X; Wei R; Zhang A; Chen H; Shi W; Xia L
    Ann Hematol; 2023 Nov; 102(11):3205-3216. PubMed ID: 37682324
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Venous Thromboembolism Incidence and Risk Factors in Patients Undergoing Hematopoietic Stem Cell Transplantation.
    Benfield M; He J; Arnall J; Kaizen W; Jandrisevits E; Eboli-Lopes K; Dodd B; Grunwald MR; Avalos B; Copelan E; Patel JN
    Transplant Cell Ther; 2024 Nov; ():. PubMed ID: 39505211
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Allogeneic Hematopoietic Cell Transplant For Bone Marrow Failure or Myelodysplastic Syndrome in Dyskeratosis Congenita/Telomere Biology Disorders: Single-Center, Single-Arm, Open-Label Trial of Reduced-Intensity Conditioning Without Radiation.
    Dimitrov M; Merkle S; Cao Q; Tryon RK; Vercellotti GM; Holtan SG; Kao RL; Srikanthan M; Terezakis SA; Tolar J; Ebens CL
    Transplant Cell Ther; 2024 Oct; 30(10):1005.e1-1005.e17. PubMed ID: 39002862
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The efficacy and safety of the prophylactic application of PEG-rhG-CSF in radiotherapy with weekly concurrent chemotherapy for cervical cancer.
    Chen H; Ma Y; Wang D; Wu H; Zhang M; Xu Y; Cheng S
    BMC Cancer; 2024 Nov; 24(1):1405. PubMed ID: 39543536
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unconventional T Cells Influence Clinical Outcome After Allogeneic Hematopoietic Cell Transplantation.
    Siblany L; Stocker N; Ricard L; Brissot E; Duléry R; Banet A; Sestili S; Belhocine R; Van de Wyngaert Z; Bonnin A; Capes A; Ledraa T; Beurier P; Fadel K; Mohty M; Gaugler B; Malard F
    J Clin Immunol; 2024 Jun; 44(6):139. PubMed ID: 38822857
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.